123 related articles for article (PubMed ID: 38035921)
1. Ankle systolic pressure index in non-diabetic non-alcoholic fatty liver disease: A case-control study.
Taharboucht S; Guermaz R; Brouri M; Bengherbia L; Chibane A
J Med Vasc; 2023; 48(5-6):154-162. PubMed ID: 38035921
[TBL] [Abstract][Full Text] [Related]
2. Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.
Taharboucht S; Guermaz R; Brouri M; Chibane A
J Med Vasc; 2021 May; 46(3):129-138. PubMed ID: 33990287
[TBL] [Abstract][Full Text] [Related]
3. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
5. Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population.
Yu XY; Zhao Y; Song XX; Song ZY
J Zhejiang Univ Sci B; 2014 Oct; 15(10):879-87. PubMed ID: 25294377
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.
Li N; Zhang GW; Zhang JR; Jin D; Li Y; Liu T; Wang RT
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):218-23. PubMed ID: 25456154
[TBL] [Abstract][Full Text] [Related]
7. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.
Zou Y; Li X; Wang C; Wang J; Wang F; Ma L; You W; Li C
Intern Med J; 2017 Oct; 47(10):1147-1153. PubMed ID: 28696562
[TBL] [Abstract][Full Text] [Related]
8. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Bajaj S; Prajapati SK
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
[TBL] [Abstract][Full Text] [Related]
10. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
11. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.
Tuttolomondo A; Petta S; Casuccio A; Maida C; Corte VD; Daidone M; Di Raimondo D; Pecoraro R; Fonte R; Cirrincione A; Zafonte R; Cabibi D; Cammà C; Di Marco V; Licata A; Magliozzo F; Marchesini G; Merlino G; Craxì A; Pinto A
Cardiovasc Diabetol; 2018 Feb; 17(1):28. PubMed ID: 29452601
[TBL] [Abstract][Full Text] [Related]
12. Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Chenbhanich J; Sanguankeo A; Rattanawong P; Wijarnpreecha K; Upala S
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):e28-e35. PubMed ID: 28542113
[TBL] [Abstract][Full Text] [Related]
13. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
[TBL] [Abstract][Full Text] [Related]
14. Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation.
Zhu W; Deng CJ; Xuan LP; Dai HJ; Zhao ZY; Wang TG; Li M; Lu JL; Xu Y; Chen YH; Wang WQ; Bi YF; Xu M
Biomed Environ Sci; 2020 Apr; 33(4):217-226. PubMed ID: 32438959
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.
Long MT; Wang N; Larson MG; Mitchell GF; Palmisano J; Vasan RS; Hoffmann U; Speliotes EK; Vita JA; Benjamin EJ; Fox CS; Hamburg NM
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1284-91. PubMed ID: 25745056
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
[TBL] [Abstract][Full Text] [Related]
17. Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.
Tanaka M; Ishii H; Aoyama T; Takahashi H; Toriyama T; Kasuga H; Takeshita K; Yoshikawa D; Amano T; Murohara T
Atherosclerosis; 2011 Dec; 219(2):643-7. PubMed ID: 22018643
[TBL] [Abstract][Full Text] [Related]
18. The association between pulse wave analysis, carotid-femoral pulse wave velocity and peripheral arterial disease in patients with ischemic heart disease.
Piko N; Bevc S; Hojs R; Naji FH; Ekart R
BMC Cardiovasc Disord; 2021 Jan; 21(1):33. PubMed ID: 33441117
[TBL] [Abstract][Full Text] [Related]
19. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.
Fennoun H; Mansouri SE; Tahiri M; Haraj NE; Aziz SE; Hadad F; Hliwa W; Badr W; Chadli A
Pan Afr Med J; 2020; 37():270. PubMed ID: 33598084
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
Yu XY; Song XX; Tong YL; Wu LY; Song ZY
Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
